Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Mar 28, 2010; 16(12): 1527-1532
Published online Mar 28, 2010. doi: 10.3748/wjg.v16.i12.1527
Table 5 Survival rate of PMTSB patients n (%)
Histopathological typeLoss of follow-up cases (n)1-yr survival rate3-yr survival rate5-yr survival rate
Adenocarcinoma (n = 61)442 (73.7)12 (21.0)9 (15.8)
GIST (n = 28)320 (80.0)18 (72.0)9 (36.0)
Carcinoid (n = 17)215 (100.0)12 (80.0)7 (46.7)
Lymphoma (n = 14)19 (9.25)4 (30.8)0
Other tumors(n = 21)113 cases of leiomyosarcoma survived (15, 39 and 71 mo, respectively) and 1 case of malignant melanoma survived 18 mo